Efficient vagina-to-lower respiratory tract immune trafficking in a murine model of influenza A virus infection.

[1]  Antonio Lanzavecchia,et al.  Central memory and effector memory T cell subsets: function, generation, and maintenance. , 2004, Annual review of immunology.

[2]  Y. Kawaoka,et al.  Mucosal and Systemic Immune Responses to a Human Immunodeficiency Virus Type 1 Epitope Induced upon Vaginal Infection with a Recombinant Influenza A Virus , 2004, Journal of Virology.

[3]  A. García-Sastre,et al.  Prime-Boost Immunization Schedules Based on Influenza Virus and Vaccinia Virus Vectors Potentiate Cellular Immune Responses against Human Immunodeficiency Virus Env Protein Systemically and in the Genitorectal Draining Lymph Nodes , 2003, Journal of Virology.

[4]  H. Katinger,et al.  Hyperattenuated Recombinant Influenza A Virus Nonstructural-Protein-Encoding Vectors Induce Human Immunodeficiency Virus Type 1 Nef-Specific Systemic and Mucosal Immune Responses in Mice , 2001, Journal of Virology.

[5]  S. Ehl,et al.  Long‐term persistence and reactivation of T cell memory in the lung of mice infected with respiratory syncytial virus , 2001, European journal of immunology.

[6]  T. Tumpey,et al.  Mucosal Delivery of Inactivated Influenza Vaccine Induces B-Cell-Dependent Heterosubtypic Cross-Protection against Lethal Influenza A H5N1 Virus Infection , 2001, Journal of Virology.

[7]  P. Doherty,et al.  Measuring the diaspora for virus-specific CD8+ T cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Alan D. Roberts,et al.  Protection from Respiratory Virus Infections Can Be Mediated by Antigen-Specific Cd4+ T Cells That Persist in the Lungs , 2001, The Journal of experimental medicine.

[9]  L. Lefrançois,et al.  Preferential Localization of Effector Memory Cells in Nonlymphoid Tissue , 2001, Science.

[10]  Alan D. Roberts,et al.  Activated Antigen-Specific CD8+ T Cells Persist in the Lungs Following Recovery from Respiratory Virus Infections1 , 2001, The Journal of Immunology.

[11]  J. Mcghee,et al.  Heterosubtypic immunity to influenza A virus infection requires B cells but not CD8+ cytotoxic T lymphocytes. , 2001, The Journal of infectious diseases.

[12]  P. Coursaget,et al.  Nasal Immunization of Mice with Human Papillomavirus Type 16 (HPV-16) Virus-Like Particles or with the HPV-16 L1 Gene Elicits Specific Cytotoxic T Lymphocytes in Vaginal Draining Lymph Nodes , 1999, Journal of Virology.

[13]  L. Lefrançois,et al.  Induction and visualization of mucosal memory CD8 T cells following systemic virus infection. , 1999, Journal of immunology.

[14]  J. Mcghee,et al.  Heterosubtypic immunity to lethal influenza A virus infection is associated with virus-specific CD8(+) cytotoxic T lymphocyte responses induced in mucosa-associated tissues. , 1999, Virology.

[15]  S. Parker,et al.  Intranasal immunization with plasmid DNA-lipid complexes elicits mucosal immunity in the female genital and rectal tracts. , 1999, Journal of immunology.

[16]  J. Altman,et al.  Virus-specific CD8+ T cells in primary and secondary influenza pneumonia. , 1998, Immunity.

[17]  K. Rosenthal,et al.  Long-term immunity and protection against herpes simplex virus type 2 in the murine female genital tract after mucosal but not systemic immunization. , 1998, The Journal of infectious diseases.

[18]  E. Parr,et al.  Immunity to vaginal infection by herpes simplex virus type 2 in adult mice: characterization of the immunoglobulins in vaginal mucus. , 1998, Journal of reproductive immunology.

[19]  J. Altman,et al.  Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. , 1998, Immunity.

[20]  J. Bennink,et al.  Mechanism of protective immunity against influenza virus infection in mice without antibodies. , 1998, Journal of immunology.

[21]  G L Ada,et al.  Options for the control of influenza III. Cairns, North Queensland, Australia (4-9 May 1996). , 1997, Vaccine.

[22]  K. Rosenthal,et al.  Long-lived cytotoxic T lymphocyte memory in mucosal tissues after mucosal but not systemic immunization , 1996, The Journal of experimental medicine.

[23]  H. Pircher,et al.  On the role of antigen in maintaining cytotoxic T-cell memory. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[24]  A. Trkola,et al.  Mucosal model of immunization against human immunodeficiency virus type 1 with a chimeric influenza virus , 1995, Journal of virology.

[25]  M. Marinaro,et al.  Mucosal immunity to infection with implications for vaccine development. , 1994, Current opinion in immunology.

[26]  K. Mozdzanowska,et al.  Heterosubtypic immunity to influenza type A virus in mice. Effector mechanisms and their longevity. , 1994, Journal of immunology.

[27]  J. Ulmer,et al.  Heterologous protection against influenza by injection of DNA encoding a viral protein. , 1993, Science.

[28]  P. Doherty,et al.  Cellular events in the lymph node and lung of mice with influenza. Consequences of depleting CD4+ T cells. , 1990, Journal of immunology.

[29]  J. Rothbard,et al.  Enhanced recognition of a modified peptide antigen by cytotoxic T cells specific for influenza nucleoprotein , 1988, Cell.

[30]  D. Wraith,et al.  Purified influenza virus nucleoprotein protects mice from lethal infection. , 1987, The Journal of general virology.

[31]  B. Askonas,et al.  Influenza nucleoprotein-specific cytotoxic T-cell clones are protective in vivo. , 1986, Immunology.

[32]  B. Moss,et al.  Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[33]  J. Bienenstock,et al.  THE MUCOSAL IMMUNOLOGICAL NETWORK: COMPARTMENTALIZATION OF LYMPHOCYTES, NATURAL KILLER CELLS, AND MAST CELLS * , 1983, Annals of the New York Academy of Sciences.

[34]  R. Webster,et al.  Changes in the antigenicity of the hemagglutinin molecule of H3 influenza virus at acidic pH. , 1983, Virology.

[35]  R B Couch,et al.  Immunity to influenza in man. , 1983, Annual review of microbiology.

[36]  J. Bienenstock,et al.  Evidence for a common mucosal immunologic system. I. Migration of B immunoblasts into intestinal, respiratory, and genital tissues. , 1979, Journal of immunology.

[37]  H. S. Kaye,et al.  Measurement of hemagglutination-inhibiting antibody to influenza virus in the 1976 influenza vaccine program: methods and test reproducibility. , 1977, The Journal of infectious diseases.